2005•Pharmaceutical Care and ResearchRequires access

Pharmacoeconomic analysis of two schemes of levofloxacin therapy for lower respiratory tract infection

Fang Qian

Abstract

Objective: To investigate the economic effectiveness of two schemes of levofloxacin therapy for patients with lower respiratory tract infection (LRTI). Methods: Forty cases of LRTI were divided into two groups: levofloxacin intravenous injection (iv) group (group A) and levofloxacin iv-oral sequential treatment group (group B). Clinical effectiveness was observed, and cost-effectiveness analysis and modeling studies were carried out. Results: The total costs were 1 081.20 yuan and 773.28 yuan, respectively (P0.05) and the effective rates were 85.7% and 84.2% (P0.05) in group A and group B, respectively. Conclusion: The iv-oral sequential levofloxacin scheme is better one for treating LRTI.

About this research paper

What this paper is about

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Key concepts: Levofloxacin, Medicine, Lower respiratory tract infection, Respiratory tract infections, Respiratory tract, Group A, Internal medicine, Respiratory system